These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 17508493)
21. Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Navi D; Huntley A Dermatol Online J; 2004 Jul; 10(1):4. PubMed ID: 15347486 [TBL] [Abstract][Full Text] [Related]
22. The clinical evidence and the role of imiquimod in the extramammary Paget disease. Iavazzo C; Ntziora F; Karachalios C; Evangelia Iavazzo P; Gkegkes ID Acta Dermatovenerol Croat; 2014; 22(2):103-9. PubMed ID: 25102795 [TBL] [Abstract][Full Text] [Related]
24. Patient Perception of Imiquimod Treatment for Actinic Keratosis and Superficial Basal Cell Carcinoma in 202 Patients. Waalboer-Spuij R; Holterhues C; van Hattem S; Schuttelaar ML; Gaastra MT; Kuijpers DI; Hollestein LM; Nijsten TE Dermatology; 2015; 231(1):56-62. PubMed ID: 25925162 [TBL] [Abstract][Full Text] [Related]
25. Eradication of basal cell cancer in an HIV positive patient with topical imiquimod. Scott DR J Drugs Dermatol; 2004; 3(6):602. PubMed ID: 15624742 [No Abstract] [Full Text] [Related]
26. Two cases of squamous cell carcinoma treated with topical imiquimod 5%. Oster-Schmidt C J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):93-5. PubMed ID: 14678542 [TBL] [Abstract][Full Text] [Related]
27. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma. Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202 [No Abstract] [Full Text] [Related]
28. Imiquimod 5% cream (Aldara) in the treatment of basal cell carcinoma. Sapijaszko MJ Skin Therapy Lett; 2005; 10(6):2-5. PubMed ID: 16292452 [TBL] [Abstract][Full Text] [Related]
29. Treatment of primary extramammary Paget's disease of the perineum with topical imiquimod 5% cream. Dias Coelho J; Vale E; Viana I; Martins O Eur J Dermatol; 2010; 20(4):532-3. PubMed ID: 20566431 [No Abstract] [Full Text] [Related]
31. Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons. Chitwood K; Etzkorn J; Cohen G Dermatol Surg; 2013 Sep; 39(9):1306-16. PubMed ID: 23915332 [TBL] [Abstract][Full Text] [Related]
32. Topical immunomodulation in dermatology: potential of toll-like receptor agonists. Hengge UR; Ruzicka T Dermatol Surg; 2004 Aug; 30(8):1101-12. PubMed ID: 15274700 [TBL] [Abstract][Full Text] [Related]
33. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage. Neville JA; Williford PM; Jorizzo JL J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362 [TBL] [Abstract][Full Text] [Related]
34. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream. van Meurs T; van Doorn R; Kirtschig G Dermatol Surg; 2007 May; 33(5):623-6; discussion 626-7. PubMed ID: 17451589 [No Abstract] [Full Text] [Related]
35. Role of imiquimod in skin cancer treatment. Urosevic M; Dummer R Am J Clin Dermatol; 2004; 5(6):453-8. PubMed ID: 15663342 [TBL] [Abstract][Full Text] [Related]